Enzalutamide
Overview
Enzalutamide is an androgen receptor inhibitor used primarily in the treatment of metastatic castration-resistant prostate cancer. It works by blocking the action of male hormones that fuel the growth of cancer cells in the prostate.
API suppliers (29)
Suppliers of Enzalutamide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 25 of 29 suppliers.
16 of 29 hold a GMP certificate on record in the EU or UK registers
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- SHILPA PHARMA LIFESCIENCES LTDIndia1 active DMF
- Zydus Lifesciences LimitedIndia1 active DMF GMP on record
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- Laurus Labs LimitedIndia1 active DMF GMP on record
- Aurisco Pharmaceutical Co.,ltdChina1 active DMF GMP on record
- Cipla USA, Inc.USA1 active DMF
- AARTI PHARMALABS LIMITEDIndia1 active DMF
- Hetero Labs LimitedIndia1 active DMF GMP on record
- SynthonNetherlands1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- Jiangxi Kvvit Pharmaceutical Co., Ltd.China1 active DMF
- CDYMAX (INDIA) PHARMA PRIVATE LIMITEDIndia1 active DMF GMP on record
- Shandong Anhong Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChina1 active DMF GMP on record
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.China1 active DMF
- BDR LIFESCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- Sichuan Kelun Pharmaceutical Co., Ltd.China1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTDChina1 active DMF
- Biocon LimitedIndia1 active DMF
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
Showing 25 of 29 suppliers — see the full list in the app.
Patent & exclusivity (US)
Per the FDA Orange Book (5 approved US products), the latest listed US patent on Enzalutamide expires 23 Feb 2037 and exclusivity 17 Nov 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Enzalutamide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.